Impact of Newly Diagnosed Left Bundle Branch Block on Long-Term Outcomes in Patients with STEMI
Larisa Anghel1,2, Cristian Stătescu1,2, Radu Andy Sascău1,2
1Internal Medicine Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700503 Iași, Romania.
Insights
Newly developed left bundle branch block (LBBB) in ST-elevation myocardial infarction (STEMI) patients significantly increases long-term risks for adverse outcomes, including mortality. Early intervention for factors like reduced ejection fraction is crucial for improving prognosis.
Area of Science:
- Cardiology
- Clinical Research
- Internal Medicine
Background:
- Left bundle branch block (LBBB) is a known cardiac condition.
- Its prognostic implications in ST-elevation myocardial infarction (STEMI) patients with single coronary lesions are not fully understood.
- Primary percutaneous coronary intervention (PCI) is a standard treatment for STEMI.
Purpose of the Study:
- To assess the long-term prognostic significance of new-onset LBBB in STEMI patients with a single coronary lesion after primary PCI.
- To identify predictors of adverse outcomes in this patient cohort.
Main Methods:
- Retrospective analysis of 3526 STEMI patients admitted between 2011-2013.
- Identified 42 patients with new-onset LBBB and a single coronary lesion, compared to 42 STEMI patients without LBBB.
- Prospective follow-up for a median of 9.4 years, analyzing demographic, clinical, and laboratory data.
Main Results:
- Patients with new-onset LBBB (n=42) showed significantly higher rates of recurrent myocardial infarction, revascularization, and mortality compared to controls (n=42).
- Multivariate analysis identified LBBB (HR: 2.15), lower left ventricular ejection fraction (LVEF) (HR: 1.45), and longer pain-to-admission time (HR: 1.32) as independent predictors of adverse outcomes.
- Baseline characteristics were similar between the groups.
Conclusions:
- Newly acquired LBBB in STEMI patients is associated with poorer long-term prognosis.
- Early identification and management of reduced LVEF and timely hospital admission are vital for improving outcomes in STEMI patients with new-onset LBBB.
Abstract:
Background/Objectives: This study assessed the long-term prognostic implications of newly developed left bundle branch block (LBBB) in patients with ST-elevation myocardial infarction (STEMI) and a single coronary lesion, following primary percutaneous coronary intervention (PCI). Methods: Among 3526 patients admitted with acute myocardial infarction between January 2011 and December 2013, 42 were identified with STEMI, a single coronary lesion, and newly diagnosed LBBB. A control group of 42 randomly selected STEMI patients without LBBB was also included. All participants were prospectively evaluated with a median follow-up duration of 9.4 years. Demographic, clinical, and laboratory data were analyzed to assess the impact of LBBB on long-term outcomes. Results: The baseline characteristics were similar between the groups. The STEMI with new LBBB group had significantly higher rates of new myocardial infarction, revascularization, and mortality, highlighting the severe prognostic implications and elevated risk for adverse outcomes compared to STEMI without LBBB. The multivariate Cox regression analysis demonstrated that the presence of LBBB (HR: 2.15, 95% CI: 1.28-3.62, p = 0.003), lower LVEF (HR: 1.45, 95% CI: 1.22-1.72, p < 0.001), and longer pain-to-admission time (HR: 1.32, 95% CI: 1.09-1.61, p = 0.008) were significant independent predictors of adverse outcomes. Conclusions: Newly acquired LBBB in STEMI patients is associated with poorer long-term outcomes. Early identification and management of factors such as reduced LVEF and timely hospital admission, specifically in patients with new-onset LBBB, can improve prognosis.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Acute Coronary SyndromeI: Introduction
Mitral Stenosis I: Introduction
Heart Failure Drugs: β-Blockers
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic studies
